|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
15
|
|
pubmed:dateCreated |
1999-3-16
|
|
pubmed:abstractText |
To compare the cost and effectiveness of bedtime intermediate-acting insulin and daytime-sulfonylurea (SU) combination therapy versus the conventional two-daily-dose insulin treatment.
|
|
pubmed:language |
spa
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0025-7753
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
7
|
|
pubmed:volume |
111
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
568-72
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9859089-Body Mass Index,
pubmed-meshheading:9859089-Cost of Illness,
pubmed-meshheading:9859089-Diabetes Mellitus, Type 1,
pubmed-meshheading:9859089-Drug Therapy, Combination,
pubmed-meshheading:9859089-Female,
pubmed-meshheading:9859089-Follow-Up Studies,
pubmed-meshheading:9859089-Humans,
pubmed-meshheading:9859089-Hypoglycemic Agents,
pubmed-meshheading:9859089-Insulin,
pubmed-meshheading:9859089-Male,
pubmed-meshheading:9859089-Prospective Studies,
pubmed-meshheading:9859089-Severity of Illness Index,
pubmed-meshheading:9859089-Sulfonylurea Compounds
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
[Medication use in diabetes mellitus (VI). Economics and effectiveness of insulin and sulfonyl-urea combination therapy compared with conventional two daily doses].
|
|
pubmed:affiliation |
Unitat de Diabetis, Hospital de Móra d'Ebre, Tarragona. bcosta@tinet.fut.es
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
English Abstract
|
